Recombinant Escherichia coli O17:K52:H18 Elongation factor Ts (tsf)

What is Elongation Factor Ts and what is its role in protein synthesis?

Elongation Factor Ts (EF-Ts) is a critical protein involved in translational elongation during protein synthesis. In the bacterial system, EF-Ts functions specifically as the guanine nucleotide exchange factor for Elongation Factor Tu (EF-Tu), catalyzing the release of GDP from EF-Tu . This exchange is essential for the continued functioning of EF-Tu in delivering aminoacyl-tRNAs to the ribosome during protein synthesis. In E. coli, this process occurs at a remarkably rapid rate of 15-20 amino acids per second (approximately 45-60 nucleotides per second) . The tsf gene encodes EF-Ts in E. coli, and its proper expression and function are essential for bacterial growth and survival.

How does E. coli O17:K52:H18 differ from other E. coli strains in terms of EF-Ts expression?

E. coli O17:K52:H18 belongs to the O11/O17/O77:K52:H18 clonal group, also known as clonal group A, which has been identified as an extraintestinal pathogenic E. coli (ExPEC) . While the basic function of EF-Ts remains consistent across E. coli strains, subtle variations in the tsf gene sequence and expression patterns may exist in this specific serotype. Research has demonstrated that this particular clonal group can cause diverse non-urinary tract extraintestinal infections, suggesting potential unique characteristics in protein expression patterns, including those of translational machinery components like EF-Ts . The distinctive virulence profile of this strain may be partially attributed to variations in essential cellular machinery proteins, though direct comparative studies specifically examining EF-Ts expression differences among various E. coli serotypes remain limited in the current literature.

What structural features distinguish EF-Ts from E. coli O17:K52:H18?

Elongation Factor Ts from E. coli O17:K52:H18 shares the core structural elements common to bacterial EF-Ts proteins, consisting of multiple domains designed to interact with EF-Tu and facilitate the GDP-GTP exchange process. While the specific structural details of EF-Ts from the O17:K52:H18 strain have not been extensively characterized in the literature, bacterial EF-Ts generally functions through domain-specific interactions with EF-Tu . The protein likely contains conserved binding sites for EF-Tu interaction that are critical for its guanine nucleotide exchange factor activity. Any strain-specific structural variations would be of particular interest to researchers studying the potential correlation between translational machinery components and the enhanced virulence observed in this extraintestinal pathogenic E. coli strain.

What are the optimal conditions for expressing recombinant EF-Ts in E. coli O17:K52:H18?

When designing experiments for optimal expression of recombinant EF-Ts in E. coli O17:K52:H18, researchers should consider several key factors. First, selection of an appropriate expression vector with a promoter compatible with this specific strain is essential. For recombinant protein expression in E. coli, it's important to note that proteins expressed in this system will not be glycosylated, unlike those expressed in insect or mammalian cell systems . This characteristic can be advantageous when studying the function of non-glycosylated proteins like EF-Ts.

For optimal expression, researchers should conduct preliminary experiments testing different induction conditions (temperature, inducer concentration, and induction time). Typically, lower temperatures (16-25°C) during induction can increase the solubility of recombinant proteins. Additionally, the composition of the growth medium can significantly impact protein yield, with enriched media often preferred for higher expression levels. When working with this specific pathogenic strain, appropriate biosafety measures must be implemented, as E. coli O17:K52:H18 belongs to a clonal group known to cause serious extraintestinal infections .

How should I design a randomized block experiment to study EF-Ts function in different E. coli strains?

When designing a randomized block experiment to compare EF-Ts function across different E. coli strains, including O17:K52:H18, the following methodological approach is recommended:

• Block Identification: Identify potential sources of variation that are not related to your primary research question about EF-Ts function. These could include batch effects, laboratory conditions, or reagent lots .

• Experimental Units: Each E. coli strain serves as an experimental unit. Include the O17:K52:H18 strain alongside other relevant strains for comparison .

• Treatments: Define your treatments clearly, which might include different conditions to assess EF-Ts function (e.g., various stressors, growth conditions, or substrate concentrations) .

• Randomization Within Blocks: Within each block, randomly assign treatments to experimental units to minimize systematic bias .

• Controls: Include appropriate positive and negative controls, such as strains with known EF-Ts activity levels or knockout strains.

This blocking approach will enable you to make more precise comparisons among the E. coli strains by controlling for extraneous variability. For example, if you're examining EF-Ts activity across three E. coli strains (including O17:K52:H18) under different temperature conditions, each temperature would be tested with all strains within the same experimental block, thereby isolating the effects due to strain differences .

What statistical approaches are most appropriate for analyzing EF-Ts expression data?

When analyzing EF-Ts expression data from recombinant E. coli O17:K52:H18, several statistical approaches are recommended:

• ANOVA: For comparing EF-Ts expression levels across multiple conditions or strains, Analysis of Variance is appropriate. When using randomized block designs, a two-way ANOVA can account for both treatment effects and block effects .

• Principal Component Analysis (PCA): This technique is useful for multivariate data analysis, particularly when examining how EF-Ts expression correlates with other variables like bacterial growth rates or protein synthesis efficiency. PCA reduction can be performed to capture a high percentage (e.g., 95%) of the explained variance, helping to identify which variables have the greatest impact on experimental outcomes .

• Regression Analysis: To establish relationships between EF-Ts expression levels and functional outcomes (e.g., translation rates, bacterial fitness).

• Data Standardization: Prior to statistical analysis, data standardization is essential when variables have widely differing ranges, as is often the case with molecular biology data . This is particularly important before performing PCA.

• Post-hoc Tests: For significant ANOVA results, follow up with appropriate post-hoc tests (e.g., Tukey's HSD) to identify specific differences between conditions.

When reporting statistical results, include measures of central tendency along with dispersion (means with standard deviations or standard errors), effect sizes, and precise p-values to enhance reproducibility.

How does the activity of recombinant EF-Ts from E. coli O17:K52:H18 compare to that from non-pathogenic strains?

The comparative activity analysis of recombinant EF-Ts from pathogenic E. coli O17:K52:H18 versus non-pathogenic strains presents an intriguing research question. E. coli O17:K52:H18 belongs to clonal group A, which has demonstrated capability for causing diverse extraintestinal infections beyond urinary tract infections . This pathogenic versatility may potentially correlate with functional differences in essential cellular machinery proteins like EF-Ts.

When conducting comparative activity assays, researchers should measure the GDP-GTP exchange rate facilitated by EF-Ts, as this reflects its primary function as a guanine nucleotide exchange factor for EF-Tu . Methodologically, this requires:

• Purification of recombinant EF-Ts to comparable levels from both pathogenic and non-pathogenic strains.

• Development of a quantitative assay measuring nucleotide exchange rates using purified EF-Tu and labeled GDP/GTP.

• Standardization of reaction conditions to ensure fair comparisons.

Any observed differences in kinetic parameters (kcat, Km) between the pathogenic and non-pathogenic EF-Ts variants could provide insights into whether translational machinery adaptations contribute to virulence characteristics. The research should also examine whether EF-Ts from O17:K52:H18 shows altered thermal stability or pH optimum compared to non-pathogenic variants, as these properties could influence bacterial adaptation to host environments during infection.

What role might EF-Ts play in the virulence of extraintestinal pathogenic E. coli strains like O17:K52:H18?

The potential relationship between EF-Ts and virulence in extraintestinal pathogenic E. coli (ExPEC) strains such as O17:K52:H18 represents an emergent research area. While EF-Ts is primarily known for its role in translation, several mechanistic hypotheses may explain its potential contribution to virulence:

• Enhanced Stress Adaptation: Optimized translational machinery including EF-Ts might allow pathogenic strains to rapidly adapt protein synthesis during infection-related stress conditions.

• Selective Translation: Variations in EF-Ts efficiency could potentially prioritize the translation of virulence-associated mRNAs under specific conditions.

• Host-Pathogen Interaction: EF-Ts might have secondary functions beyond translation that directly interact with host cellular components.

Research examining this question should employ a multifaceted approach including:

• Creation of EF-Ts variants with site-specific mutations to identify regions important for both canonical function and virulence.

• Comparison of global translation profiles between wild-type and EF-Ts-modified strains during infection-mimicking conditions.

• In vivo infection models to assess how EF-Ts modifications impact colonization and disease progression.

E. coli O17:K52:H18 and related strains in clonal group A are particularly relevant for this investigation as they demonstrate remarkable extraintestinal pathogenic versatility, causing infections ranging from pneumonia to deep surgical wound infections and vertebral osteomyelitis . Understanding how fundamental cellular machinery like EF-Ts might contribute to this pathogenic potential could reveal novel therapeutic targets.

How do post-translational modifications affect EF-Ts function in E. coli O17:K52:H18?

For EF-Ts, potential PTMs to investigate include:

• Phosphorylation: Which could regulate nucleotide exchange activity

• Methylation: Potentially affecting protein-protein interactions

• Acetylation: Which might influence protein stability or localization

Methodological approaches should include:

• Mass spectrometry analysis of purified native EF-Ts from E. coli O17:K52:H18 to identify and map PTMs

• Site-directed mutagenesis of identified modification sites to create non-modifiable variants

• Functional comparison between wild-type and modification-site mutants using GDP-GTP exchange assays

• Structural analysis to determine how modifications affect EF-Ts interaction with EF-Tu

The pathogenic nature of E. coli O17:K52:H18 raises the intriguing possibility that strain-specific PTM patterns on essential cellular machinery might contribute to its virulence characteristics . Comparing PTM profiles between pathogenic and non-pathogenic strains could reveal regulatory mechanisms specific to extraintestinal pathogenic E. coli that enable their adaptation to diverse infection sites.

What purification protocol yields the highest purity of recombinant EF-Ts from E. coli O17:K52:H18?

For optimal purification of recombinant EF-Ts from E. coli O17:K52:H18, a multi-step protocol is recommended:

• Initial Clarification:

  • Harvest bacterial cells and resuspend in an appropriate buffer (typically 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM β-mercaptoethanol)

  • Lyse cells using sonication or high-pressure homogenization

  • Centrifuge at 20,000 × g for 30 minutes to remove cell debris

• Affinity Chromatography:

  • If using a His-tagged construct, apply clarified lysate to a Ni-NTA column

  • Wash with increasing imidazole concentrations (10-40 mM) to remove non-specifically bound proteins

  • Elute EF-Ts with higher imidazole concentration (250-300 mM)

• Ion Exchange Chromatography:

  • Dialyze affinity-purified protein to remove imidazole

  • Apply to an anion exchange column (e.g., Q-Sepharose)

  • Elute using a linear salt gradient (0-500 mM NaCl)

• Size Exclusion Chromatography:

  • As a final polishing step, apply concentrated protein to a gel filtration column

  • Collect fractions containing monomeric EF-Ts

Throughout purification, protein concentration can be determined using standard methods such as Bradford assay or absorbance at 280 nm. When reconstituting lyophilized protein, a concentration between 0.1-1.0 mg/mL is recommended, as indicated for general recombinant proteins . For example, 100 μg of protein should be reconstituted in 100 μL to 1 mL of appropriate buffer, resulting in a concentration between 0.1-1.0 mg/mL .

For purification quality assessment, SDS-PAGE should show >95% purity, and activity assays measuring GDP-GTP exchange rates should be performed to confirm functional integrity.

How can researchers validate the structural integrity and activity of purified recombinant EF-Ts?

Validating both the structural integrity and functional activity of purified recombinant EF-Ts from E. coli O17:K52:H18 requires a comprehensive approach using multiple complementary techniques:

Structural Integrity Assessment:

• Circular Dichroism (CD) Spectroscopy: Evaluates secondary structure elements and proper protein folding.

• Thermal Shift Assay: Determines protein stability and proper folding through melting temperature (Tm) analysis.

• Size Exclusion Chromatography coupled with Multi-Angle Light Scattering (SEC-MALS): Confirms the monomeric state and molecular weight of the purified protein.

• Limited Proteolysis: Properly folded proteins typically display characteristic proteolytic patterns when subjected to controlled digestion.

Functional Activity Validation:

• GDP Exchange Assay: The primary functional test measuring EF-Ts activity in catalyzing GDP release from EF-Tu . This can be quantified using:

  • Fluorescently labeled GDP analogs

  • Radioactive GDP

  • Coupled enzyme assays that measure phosphate release

• EF-Tu Binding Assay: Using techniques like surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to measure binding kinetics and affinity between EF-Ts and EF-Tu.

• In vitro Translation Assay: Testing whether the addition of purified EF-Ts enhances translation efficiency in a cell-free protein synthesis system.

When conducting these validation tests, it's important to include appropriate controls, such as commercially available E. coli EF-Ts or a well-characterized laboratory strain EF-Ts for comparison. The activity measurements should be reported in standardized units, and where possible, compared against International Unit (IU) values through side-by-side comparisons with reference standards .

What are the critical factors affecting recombinant EF-Ts stability during storage and experimentation?

Multiple factors critically impact the stability of recombinant EF-Ts from E. coli O17:K52:H18 during storage and experimental procedures:

Storage Conditions:

• Temperature: Store purified EF-Ts at -80°C for long-term stability. For working stocks, -20°C is generally acceptable, while 4°C should only be used for short-term storage (1-2 weeks maximum).

• Buffer Composition:

  • pH: Maintain pH 7.0-7.5 for optimal stability

  • Salt concentration: 100-150 mM NaCl typically provides stability

  • Reducing agents: Include 1-5 mM DTT or β-mercaptoethanol to prevent oxidation of cysteine residues

  • Glycerol: Addition of 10-20% glycerol can improve freeze-thaw stability

• Aliquoting: Divide purified protein into single-use aliquots to minimize freeze-thaw cycles, which can significantly reduce activity.

Experimental Considerations:

• Freeze-Thaw Cycles: Each cycle can reduce activity by 5-15%. Limit to ≤3 cycles for reliable results.

• Temperature Sensitivity: EF-Ts function is temperature-dependent, with optimal activity typically observed at physiological temperatures (37°C for E. coli proteins).

• Metal Ion Requirements: Some EF-Ts functions may depend on specific metal ions like magnesium; ensure appropriate concentrations in experimental buffers.

• Protein Concentration: Extremely dilute solutions (<0.1 mg/mL) can lead to protein adsorption to container surfaces and apparent activity loss . If working with low concentrations, consider adding carrier proteins like BSA (0.1%) to prevent surface adsorption.

• Oxidative Damage: Exposure to oxidizing agents should be minimized as they can disrupt structure and function.

When reconstituting lyophilized EF-Ts, follow the specific instructions for the product, but generally aim for concentrations between 0.1-1.0 mg/mL . Proper centrifugation of the container before opening is recommended to ensure the lyophilized powder is at the bottom of the tube .

How does EF-Ts from E. coli O17:K52:H18 compare with homologous proteins from eukaryotic systems?

Bacterial EF-Ts, including that from E. coli O17:K52:H18, differs significantly from its eukaryotic counterpart (eEF-1B) in several important aspects:

Structural Comparison:

Functional Comparison:

While both bacterial EF-Ts and eukaryotic eEF-1B serve as guanine nucleotide exchange factors, they exhibit notable differences in their kinetic properties . The bacterial elongation phase proceeds at approximately 15-20 amino acids per second, whereas the eukaryotic process is considerably slower at about 2 amino acids per second . This difference in translation speed may be partially attributed to the distinct properties of their respective elongation factors.

Evolutionary Significance:

The structural and functional differences between bacterial and eukaryotic elongation factors make bacterial EF-Ts, including that from pathogenic strains like E. coli O17:K52:H18, potential targets for antimicrobial development. The fact that certain E. coli strains like O17:K52:H18 can cause serious extraintestinal infections adds clinical relevance to understanding these molecular differences.

Researchers studying EF-Ts from E. coli O17:K52:H18 should be aware that findings may not directly translate to eukaryotic systems due to these fundamental differences in elongation factor structure and function. These differences also present opportunities for comparative biochemical studies that could reveal evolutionary adaptations in translational machinery.

What experimental approaches can detect interaction partners of EF-Ts in E. coli O17:K52:H18?

To comprehensively identify and characterize interaction partners of EF-Ts in E. coli O17:K52:H18, researchers should employ multiple complementary techniques:

In vivo Approaches:

• Bacterial Two-Hybrid System:

  • Construct fusion proteins between EF-Ts and a DNA-binding domain

  • Screen against a genomic library fused to an activation domain

  • This allows detection of interactions in a bacterial cellular environment

• Co-Immunoprecipitation (Co-IP) with Antibody Specific to EF-Ts:

  • Use strain-specific antibodies against EF-Ts or epitope tags if using recombinant systems

  • Coupled with mass spectrometry for unbiased identification of interaction partners

  • Validate results with reverse Co-IP using antibodies against identified partners

• Proximity-Dependent Biotin Identification (BioID):

  • Express EF-Ts fused to a biotin ligase in E. coli O17:K52:H18

  • Nearby proteins become biotinylated and can be purified using streptavidin

  • Identify biotinylated proteins by mass spectrometry

In vitro Approaches:

• Pull-Down Assays:

  • Immobilize purified recombinant EF-Ts on appropriate resin

  • Incubate with E. coli O17:K52:H18 lysate

  • Identify bound proteins using mass spectrometry

• Surface Plasmon Resonance (SPR):

  • Immobilize EF-Ts on sensor chip

  • Flow candidate interacting proteins over the surface

  • Measure binding kinetics and affinity constants

• Crosslinking Mass Spectrometry:

  • Use chemical crosslinkers to capture transient interactions

  • Digest crosslinked complexes and identify using specialized mass spectrometry approaches

The experimental design should include proper controls to distinguish specific from non-specific interactions. For randomized block designs in interaction studies, factors such as bacterial growth phase, media conditions, and strain variations should be blocked to minimize experimental variability .

When analyzing interaction data, statistical approaches such as ANOVA for quantitative interaction strength comparisons or principal component analysis for multi-variable datasets can help identify significant patterns .

How can recombinant EF-Ts be utilized in developing novel antimicrobial strategies against pathogenic E. coli strains?

Recombinant EF-Ts from E. coli O17:K52:H18 offers several promising avenues for developing targeted antimicrobial strategies against pathogenic E. coli strains:

As a Drug Target:

• High-Throughput Screening Platforms:

  • Use purified recombinant EF-Ts in assays measuring nucleotide exchange activity

  • Screen compound libraries for specific inhibitors of EF-Ts function

  • Focus on compounds that selectively inhibit bacterial but not human elongation factors

• Structure-Based Drug Design:

  • Determine the three-dimensional structure of E. coli O17:K52:H18 EF-Ts

  • Identify unique pockets not present in human homologs

  • Design small molecules targeting these pockets using computational approaches

For Diagnostic Applications:

• Strain-Specific Antibody Development:

  • Generate antibodies against unique epitopes in O17:K52:H18 EF-Ts

  • Develop rapid diagnostic tests to identify this specific pathogenic strain

  • This approach is particularly relevant given that O17:K52:H18 belongs to clonal group A, which has been shown to cause diverse extraintestinal infections

Experimental Design Considerations:

When designing experiments to evaluate potential antimicrobial compounds targeting EF-Ts, a randomized block design approach is recommended . This would involve:

• Testing multiple potential compounds (treatments) against various E. coli strains (blocks)

• Including appropriate controls such as known antibiotics and vehicle controls

• Measuring multiple endpoints (growth inhibition, protein synthesis inhibition, etc.)

For statistical analysis of antimicrobial efficacy, ANOVA with appropriate post-hoc tests can determine significant differences between compounds . Principal component analysis may also be valuable for multivariate data integration when assessing compound effects across multiple parameters .

The development of EF-Ts-targeting antimicrobials would be particularly valuable against multidrug-resistant strains, as clonal group A (which includes O17:K52:H18) has demonstrated multidrug resistance while causing serious extraintestinal infections .

What are common challenges in expressing recombinant EF-Ts in E. coli systems and how can they be overcome?

Researchers working with recombinant EF-Ts expression in E. coli systems, including strain O17:K52:H18, frequently encounter several challenges that can be addressed through specific methodological approaches:

Challenge 1: Protein Insolubility/Inclusion Body Formation

Solution Approaches:

• Lower induction temperature (16-20°C) to slow protein synthesis and promote proper folding

• Reduce inducer concentration to decrease expression rate

• Co-express molecular chaperones (GroEL/GroES, DnaK/DnaJ) to assist protein folding

• Use solubility-enhancing fusion tags (e.g., MBP, SUMO, thioredoxin)

• Optimize buffer conditions during cell lysis (add mild detergents, adjust salt concentration)

Challenge 2: Low Expression Yield

Solution Approaches:

• Optimize codon usage for E. coli, particularly if the gene originates from a different organism

• Test different promoter systems (T7, tac, ara)

• Adjust culture medium composition (rich vs. minimal media)

• Screen multiple E. coli host strains (BL21(DE3), C41/C43, Rosetta)

• Optimize induction timing based on growth curve

Challenge 3: Proteolytic Degradation

Solution Approaches:

• Use protease-deficient host strains (BL21, which lacks lon and ompT proteases)

• Include protease inhibitors during purification

• Optimize extraction and purification buffers (pH, ionic strength)

• Reduce processing time and maintain samples at 4°C

Challenge 4: Post-Translational Modifications

It's important to recognize that E. coli expression systems do not perform glycosylation, unlike insect or mammalian expression systems . If glycosylation is required for your research:

• Consider alternative expression systems (insect cells, mammalian cells) if glycosylation is critical

• Evaluate whether the lack of glycosylation affects your specific research objectives

Challenge 5: Toxicity to Host Cells

Solution Approaches:

• Use tightly controlled inducible promoter systems

• Test expression in specialized strains designed for toxic proteins

• Consider cell-free expression systems for highly toxic proteins

For experimental design, a factorial approach testing multiple variables simultaneously (e.g., temperature, inducer concentration, host strain) can efficiently identify optimal conditions . This approach allows researchers to identify not only the individual effects of each factor but also their interactions, which is critical for optimizing complex biological processes like recombinant protein expression.

How can researchers troubleshoot issues with EF-Ts activity in functional assays?

When troubleshooting issues with recombinant EF-Ts activity in functional assays, researchers should systematically evaluate potential problems across multiple experimental dimensions:

Protein Quality Issues:

• Improper Folding:

  • Verify secondary structure using circular dichroism spectroscopy

  • Compare thermal stability profile with known active EF-Ts preparations

  • Solution: Optimize purification protocol to preserve native conformation

• Oxidative Damage:

  • Test activity in the presence of reducing agents (DTT, β-mercaptoethanol)

  • Examine for higher molecular weight bands on non-reducing SDS-PAGE indicating disulfide formation

  • Solution: Include reducing agents in all buffers and store under nitrogen or argon atmosphere

• Proteolytic Degradation:

  • Run SDS-PAGE to check for degradation products

  • Solution: Add protease inhibitors and minimize processing time

Assay Condition Problems:

• Suboptimal Buffer Components:

  • Systematically vary buffer components (pH, salt concentration, divalent cations)

  • Test activity in buffers mimicking physiological conditions

  • Solution: Perform buffer optimization series using factorial design

• Partner Protein Issues:

  • Verify activity of EF-Tu used in the assay

  • Ensure proper interaction between EF-Ts and EF-Tu using binding assays

  • Solution: Use freshly prepared EF-Tu and verify its GDP-binding activity

• Nucleotide Quality:

  • Use fresh nucleotides or verify existing stocks by HPLC

  • Solution: Purchase high-quality nucleotides and store appropriately

Methodological Approaches:

When systematically troubleshooting, employ a randomized block design to control for variables not directly being tested . For example, when testing different buffer conditions, maintain the same protein preparation across all conditions to block the effect of preparation-to-preparation variability.

For data analysis, compare activity measurements to positive controls and calculate relative activity. When analyzing multi-factor troubleshooting experiments, principal component analysis can help identify which variables most strongly influence activity .

Remember that reconstitution protocols significantly impact protein activity; for optimal results with lyophilized proteins, reconstitute to concentrations between 0.1-1.0 mg/mL using the recommended buffers, and centrifuge the container first to ensure the powder is at the bottom of the tube .

What quality control metrics should be applied when working with recombinant E. coli O17:K52:H18 EF-Ts?

Purity Assessment:

• SDS-PAGE Analysis:

  • Acceptance criterion: >95% purity by densitometric analysis

  • Method: Coomassie or silver staining with lane profile analysis

• Size Exclusion Chromatography:

  • Acceptance criterion: >90% monomeric protein with appropriate retention time

  • Method: Analytical SEC with appropriate molecular weight standards

Identity Confirmation:

• Mass Spectrometry:

  • Acceptance criterion: Measured mass within 0.1% of theoretical mass

  • Methods: ESI-MS or MALDI-TOF for intact mass; LC-MS/MS for peptide mapping

• Western Blotting:

  • Acceptance criterion: Specific binding to anti-EF-Ts antibodies

  • Method: Immunoblotting with validated antibodies

Functional Activity:

• GDP Exchange Activity:

  • Acceptance criterion: Activity within 20% of reference standard

  • Method: Fluorescent or radioactive GDP release assay

• EF-Tu Binding:

  • Acceptance criterion: KD within established range for active protein

  • Method: Surface plasmon resonance or isothermal titration calorimetry

Contaminant Testing:

• Endotoxin Testing:

  • Acceptance criterion: <1 EU/mg protein for in vitro studies; <0.1 EU/mg for in vivo studies

  • Method: LAL assay or recombinant Factor C assay

• Nucleic Acid Contamination:

  • Acceptance criterion: A260/A280 ratio <0.7

  • Method: UV spectroscopy or fluorometric quantification

Stability Indicators:

• Thermal Stability:

  • Acceptance criterion: Consistent melting temperature (±2°C)

  • Method: Differential scanning fluorimetry or circular dichroism

• Functional Stability:

  • Acceptance criterion: <20% activity loss after specified storage period

  • Method: Periodic activity testing under standardized conditions

When establishing these metrics, it's important to develop appropriate reference standards. For quantitative assays, consider obtaining International Unit (IU) values through side-by-side comparisons against WHO Reference Standards where applicable .

For statistical quality control, implement control charts to monitor batch-to-batch consistency, with standard action limits (typically ±2SD for warning, ±3SD for action) to trigger investigation of process deviations .

How might systems biology approaches advance our understanding of EF-Ts function in E. coli O17:K52:H18?

Systems biology approaches offer powerful frameworks for understanding EF-Ts function within the complex biological context of E. coli O17:K52:H18, particularly given this strain's membership in clonal group A with demonstrated extraintestinal pathogenic versatility .

Multi-omics Integration Strategies:

• Transcriptomics-Proteomics Correlation:

  • Investigate how tsf gene expression correlates with EF-Ts protein levels under various conditions

  • Identify potential post-transcriptional regulation mechanisms

  • Methodological approach: RNA-seq paired with quantitative proteomics, analyzed using multivariate statistical methods

• Protein-Protein Interaction Networks:

  • Map the complete interactome of EF-Ts beyond its canonical partner EF-Tu

  • Identify strain-specific interaction partners that might contribute to pathogenicity

  • Methodological approach: Affinity purification-mass spectrometry combined with computational network analysis

• Metabolomics Integration:

  • Correlate EF-Ts activity levels with metabolic profiles

  • Investigate whether EF-Ts activity influences specific metabolic pathways important for virulence

  • Methodological approach: Untargeted metabolomics coupled with flux analysis

Computational Modeling Approaches:

Experimental Design Considerations:

For systems biology studies, factorial experimental designs are particularly valuable as they allow examination of multiple factors simultaneously and can reveal interaction effects that might be missed in single-variable experiments . When analyzing the resulting complex datasets, dimensional reduction techniques like principal component analysis can help identify the variables with greatest impact on system behavior .

The integration of these systems biology approaches will provide a comprehensive understanding of how EF-Ts functions within the broader cellular context of E. coli O17:K52:H18, potentially revealing unexpected connections between translation machinery and pathogenic capabilities.

What are the implications of EF-Ts mutations on antibiotic resistance in pathogenic E. coli strains?

The relationship between EF-Ts mutations and antibiotic resistance in pathogenic E. coli strains like O17:K52:H18 represents an emerging research area with significant clinical implications. E. coli clonal group A, which includes the O17:K52:H18 serotype, has already demonstrated multidrug resistance capabilities while causing serious extraintestinal infections .

Potential Mechanisms Linking EF-Ts to Antibiotic Resistance:

• Translation Fidelity Effects:

  • Mutations in EF-Ts could alter translation accuracy, potentially affecting the expression of resistance genes

  • Research approach: Compare mistranslation rates between wild-type and mutant EF-Ts under antibiotic stress

• Stress Response Modulation:

  • EF-Ts variants might enhance bacterial survival under antibiotic pressure by modulating stress responses

  • Research approach: Transcriptome analysis of strains with different EF-Ts variants under antibiotic exposure

• Direct Interaction with Antibiotics:

  • Some translation machinery components can be direct targets of antibiotics; mutations might reduce binding affinity

  • Research approach: Binding studies between antibiotics and different EF-Ts variants

Experimental Approaches to Investigate These Links:

• Genetic Screening:

  • Generate libraries of EF-Ts mutants in E. coli O17:K52:H18

  • Screen for variants conferring altered antibiotic susceptibility

  • Deep sequencing to identify mutations associated with resistance

• Structure-Function Analysis:

  • Determine crystal structures of wild-type and resistant-associated EF-Ts variants

  • Molecular dynamics simulations to understand conformational changes

  • Site-directed mutagenesis to confirm the role of specific residues

• Whole-Genome Sequencing of Clinical Isolates:

  • Analyze tsf gene sequences from antibiotic-resistant clinical isolates of E. coli O17:K52:H18

  • Correlate specific mutations with resistance phenotypes

  • Population genetics analysis to track the evolution of resistance-associated mutations

Experimental Design and Analysis Considerations:

When designing experiments to investigate these relationships, randomized block designs can control for factors like genetic background and growth conditions . For data analysis, multivariate approaches like principal component analysis can help identify patterns in complex datasets spanning multiple antibiotics and EF-Ts variants .

This research direction has particular significance given that clonal group A E. coli strains, including O17:K52:H18, have demonstrated notable extraintestinal pathogenic versatility, causing infections ranging from pneumonia to deep surgical wound infection and vertebral osteomyelitis . Understanding how fundamental cellular machinery like EF-Ts might contribute to antibiotic resistance could identify novel therapeutic targets.

How can CRISPR-Cas9 technology be applied to study EF-Ts function in E. coli O17:K52:H18?

CRISPR-Cas9 technology offers revolutionary approaches for investigating EF-Ts function in E. coli O17:K52:H18 through precise genetic manipulation. This technology is particularly valuable for studying essential genes like tsf (encoding EF-Ts), where traditional knockout approaches would be lethal.

Genome Editing Applications:

• Point Mutation Introduction:

  • Create specific amino acid substitutions in the endogenous tsf gene

  • Target functional domains involved in EF-Tu interaction or nucleotide exchange

  • Methodological approach: Design single guide RNAs (sgRNAs) targeting the region of interest and provide repair templates with desired mutations

• Domain Swapping:

  • Replace specific domains of EF-Ts with corresponding regions from other bacterial species

  • Investigate the contribution of strain-specific domains to pathogenicity

  • Methodological approach: Design sgRNAs flanking domain-encoding regions and provide repair templates with heterologous sequences

• Promoter Modification:

  • Alter the native tsf promoter to create conditional or tunable expression

  • Study the effects of EF-Ts abundance on translation dynamics and bacterial fitness

  • Methodological approach: Target the promoter region with CRISPR and introduce inducible or constitutive promoters via homology-directed repair

Gene Regulation Applications:

• CRISPRi for Partial Knockdown:

  • Use catalytically inactive Cas9 (dCas9) to create a partial knockdown of tsf expression

  • Titrate EF-Ts levels to determine minimum requirements for growth and virulence

  • Methodological approach: Design sgRNAs targeting the tsf promoter or coding region and express with dCas9

• CRISPRa for Overexpression:

  • Employ CRISPR activation systems to increase tsf expression

  • Investigate the consequences of EF-Ts overabundance on translation and bacterial physiology

  • Methodological approach: Fuse transcriptional activators to dCas9 and target the tsf promoter region

Experimental Design Considerations:

When designing CRISPR experiments for E. coli O17:K52:H18, several factors require special attention:

• Delivery Methods:

  • Optimize transformation protocols specifically for this pathogenic strain

  • Consider phage-based delivery systems if transformation efficiency is low

• Off-Target Effects:

  • Perform comprehensive off-target analysis specific to the O17:K52:H18 genome

  • Include appropriate controls to distinguish phenotypes caused by on-target vs. off-target effects

• Experimental Design Strategy:

  • Employ randomized block designs when testing multiple CRISPR-created variants to control for batch effects

  • For complex phenotypic analyses, consider factorial designs to evaluate interactions between tsf modifications and environmental conditions

The application of CRISPR-Cas9 technology to study EF-Ts in E. coli O17:K52:H18 is particularly valuable given this strain's membership in clonal group A, which has demonstrated pathogenic versatility in causing serious extraintestinal infections . Understanding the molecular basis of this versatility through precise genetic manipulation could reveal new insights into bacterial pathogenesis and potential therapeutic targets.